在危急病患者中连续服用塞福他xime 达到目标 - - 一项追溯队列研究
C Stephani1, L Weber1, J Wieditz2
1Clinic for Anesthesiology, University Medical Center Göttingen, Robert Koch-Strasse 40, 37075 Göttingen, Germany.
Journal of critical care
|September 17, 2025
概括
持续的塞福他西姆剂量确保了重症患者的治疗性血水平. 功能显著影响塞福胺水平,需要剂量调整以获得最佳治疗结果.
科学领域:
- 药理动力学和药理动力学
- 临界护理医学 临界护理医学
- 传染性疾病 传染性疾病
背景情况:
- 塞福塔克西姆是治疗肺炎,败血症和脑膜炎等严重感染的重要β-lactam抗生素.
- 关于在重症患者中持续服用塞福他西姆的数据有限.
- 这项研究评估了塞福他西姆的剂量和影响其血度的因素.
研究的目的:
- 为了评估持续输注塞福他西姆在重症患者的剂量性能.
- 为了确定影响塞福他西姆血水平的临床和实验室因素.
- 优化塞福他西姆剂量策略,以改善患者的治疗结果.
主要方法:
- 追溯分析临床病情严重患者的电子病历,这些病例中患者接受持续治疗.
- 标准化充填剂量 (2g) 接着是连续输液 (6g/天).
- 对临床参数,实验室值和Cefotaxime血水平的相关性和回归分析.
主要成果:
- 在所有患者中,在最初和随后的持续治疗中,持续的塞福他西姆达到标血水平 (>8 mg/L).
- 90%的患者达到超过16mg/L的水平 (八倍MIC断点).
- 估计的淋巴细胞过率 (eGFR) 是一个重要的因素,解释了~50%的血水平变异.
结论:
- 标准的连续塞福胺剂量 (6g/天) 可靠地达到对肠道细菌的杀菌度,即使功能增强.
- 建议对正常和功能下降的患者进行剂量调整.
- 这支持持续输液作为在重症监护机构中提供塞福他西姆的有效策略.
相关概念视频
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
179
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
179
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
321
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
321
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
238
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
238
01:26Urine Studies II: Urine Culture and Sensitivity Test
879
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
879
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
233
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
233
01:28Pneumonia IV: Management
756
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
756